| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 4.01e-05 | 2 | 127 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 4.01e-05 | 2 | 127 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 4.01e-05 | 2 | 127 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 4.01e-05 | 2 | 127 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | taurine:sodium symporter activity | 1.20e-04 | 3 | 127 | 2 | GO:0005369 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ERCC6 VPS4A VPS4B FIGNL2 CHD3 RFC4 MMAA MOV10L1 CARNS1 RAD54L VCP | 1.20e-04 | 441 | 127 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.02e-04 | 188 | 127 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | taurine transmembrane transporter activity | 3.96e-04 | 5 | 127 | 2 | GO:0005368 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 5.92e-04 | 6 | 127 | 2 | GO:0005332 | |
| GeneOntologyMolecularFunction | L-leucine binding | 8.25e-04 | 7 | 127 | 2 | GO:0070728 | |
| GeneOntologyBiologicalProcess | glutamate biosynthetic process | 2.21e-06 | 5 | 126 | 3 | GO:0006537 | |
| Domain | LamG | 4.79e-07 | 44 | 126 | 6 | SM00282 | |
| Domain | Laminin_G | 2.54e-06 | 58 | 126 | 6 | IPR001791 | |
| Domain | LAM_G_DOMAIN | 5.42e-06 | 38 | 126 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 7.03e-06 | 40 | 126 | 5 | PF02210 | |
| Domain | Vps4_C | 1.64e-05 | 8 | 126 | 3 | IPR015415 | |
| Domain | Vps4_C | 1.64e-05 | 8 | 126 | 3 | PF09336 | |
| Domain | AAA | 2.60e-05 | 52 | 126 | 5 | PF00004 | |
| Domain | ATPase_AAA_core | 3.13e-05 | 54 | 126 | 5 | IPR003959 | |
| Domain | MIT | 3.48e-05 | 10 | 126 | 3 | SM00745 | |
| Domain | MIT | 3.48e-05 | 10 | 126 | 3 | PF04212 | |
| Domain | - | 4.45e-05 | 95 | 126 | 6 | 2.60.120.200 | |
| Domain | ELFV_dehydrog_N | 4.52e-05 | 2 | 126 | 2 | PF02812 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 4.52e-05 | 2 | 126 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 4.52e-05 | 2 | 126 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 4.52e-05 | 2 | 126 | 2 | IPR006095 | |
| Domain | ELFV_dehydrog | 4.52e-05 | 2 | 126 | 2 | PF00208 | |
| Domain | PIEZO | 4.52e-05 | 2 | 126 | 2 | PF15917 | |
| Domain | Piezo | 4.52e-05 | 2 | 126 | 2 | IPR027272 | |
| Domain | Piezo_RRas_bdg | 4.52e-05 | 2 | 126 | 2 | PF12166 | |
| Domain | NAD_bind_Glu_DH | 4.52e-05 | 2 | 126 | 2 | IPR033922 | |
| Domain | GLFV_DEHYDROGENASE | 4.52e-05 | 2 | 126 | 2 | PS00074 | |
| Domain | ELFV_dehydrog | 4.52e-05 | 2 | 126 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 4.52e-05 | 2 | 126 | 2 | IPR033524 | |
| Domain | Piezo_RRas-bd_dom | 4.52e-05 | 2 | 126 | 2 | IPR031334 | |
| Domain | Piezo_dom | 4.52e-05 | 2 | 126 | 2 | IPR031805 | |
| Domain | Laminin_G_1 | 4.75e-05 | 11 | 126 | 3 | PF00054 | |
| Domain | AAA | 7.83e-05 | 34 | 126 | 4 | PS00674 | |
| Domain | - | 8.16e-05 | 13 | 126 | 3 | 1.20.58.280 | |
| Domain | MIT | 1.03e-04 | 14 | 126 | 3 | IPR007330 | |
| Domain | UBA | 2.81e-04 | 47 | 126 | 4 | PS50030 | |
| Domain | AAA | 4.36e-04 | 144 | 126 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 4.36e-04 | 144 | 126 | 6 | IPR003593 | |
| Domain | - | 5.16e-04 | 55 | 126 | 4 | 1.10.30.10 | |
| Domain | ConA-like_dom | 7.19e-04 | 219 | 126 | 7 | IPR013320 | |
| Domain | AT_hook | 7.79e-04 | 27 | 126 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 7.79e-04 | 27 | 126 | 3 | IPR017956 | |
| Domain | CUT | 9.27e-04 | 7 | 126 | 2 | PS51042 | |
| Domain | CUT | 9.27e-04 | 7 | 126 | 2 | PF02376 | |
| Domain | CUT_dom | 9.27e-04 | 7 | 126 | 2 | IPR003350 | |
| Domain | CUT | 9.27e-04 | 7 | 126 | 2 | SM01109 | |
| Domain | ATPase_AAA_CS | 9.64e-04 | 29 | 126 | 3 | IPR003960 | |
| Domain | HMG_box_dom | 9.73e-04 | 65 | 126 | 4 | IPR009071 | |
| Domain | UBA | 1.07e-03 | 30 | 126 | 3 | SM00165 | |
| Domain | EGF_LAM_2 | 1.07e-03 | 30 | 126 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.07e-03 | 30 | 126 | 3 | PS01248 | |
| Domain | HEMATOPO_REC_S_F1 | 1.23e-03 | 8 | 126 | 2 | PS01355 | |
| Domain | LAMININ_IVA | 1.23e-03 | 8 | 126 | 2 | PS51115 | |
| Domain | Laminin_B | 1.23e-03 | 8 | 126 | 2 | PF00052 | |
| Domain | LamB | 1.23e-03 | 8 | 126 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.23e-03 | 8 | 126 | 2 | IPR000034 | |
| Domain | SNF2_N | 1.29e-03 | 32 | 126 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.29e-03 | 32 | 126 | 3 | PF00176 | |
| Domain | Hempt_rcpt_S_F1_CS | 1.58e-03 | 9 | 126 | 2 | IPR003531 | |
| Domain | EGF_Lam | 1.68e-03 | 35 | 126 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.68e-03 | 35 | 126 | 3 | PF00053 | |
| Domain | UBA | 1.82e-03 | 36 | 126 | 3 | PF00627 | |
| Domain | Laminin_EGF | 2.13e-03 | 38 | 126 | 3 | IPR002049 | |
| Domain | calpain_III | 2.85e-03 | 12 | 126 | 2 | SM00720 | |
| Domain | C2_III | 2.85e-03 | 12 | 126 | 2 | IPR033883 | |
| Domain | Calpain_III | 2.85e-03 | 12 | 126 | 2 | IPR022683 | |
| Domain | UBA | 3.24e-03 | 44 | 126 | 3 | IPR015940 | |
| Domain | Calpain_III | 3.35e-03 | 13 | 126 | 2 | PF01067 | |
| Domain | Calpain_domain_III | 3.35e-03 | 13 | 126 | 2 | IPR022682 | |
| Domain | SET | 3.68e-03 | 46 | 126 | 3 | SM00317 | |
| Domain | SEA | 3.90e-03 | 14 | 126 | 2 | SM00200 | |
| Domain | Calpain_cysteine_protease | 3.90e-03 | 14 | 126 | 2 | IPR022684 | |
| Domain | Peptidase_C2 | 4.48e-03 | 15 | 126 | 2 | PF00648 | |
| Domain | CysPc | 4.48e-03 | 15 | 126 | 2 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 4.48e-03 | 15 | 126 | 2 | IPR001300 | |
| Domain | CALPAIN_CAT | 4.48e-03 | 15 | 126 | 2 | PS50203 | |
| Domain | SET_dom | 4.66e-03 | 50 | 126 | 3 | IPR001214 | |
| Domain | SET | 4.66e-03 | 50 | 126 | 3 | PS50280 | |
| Domain | AT_hook | 5.09e-03 | 16 | 126 | 2 | PF02178 | |
| Domain | HMG_box | 5.49e-03 | 53 | 126 | 3 | PF00505 | |
| Domain | HMG | 5.79e-03 | 54 | 126 | 3 | SM00398 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 6.44e-03 | 18 | 126 | 2 | PS00754 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.62e-05 | 59 | 90 | 5 | M27218 | |
| Pubmed | TET2 RGPD2 TTC28 VPS4B TNRC6B CHD3 CIC RBM20 SFMBT2 PALB2 BAP1 PRR12 KMT2D TLE3 ZBTB10 | 5.29e-11 | 418 | 129 | 15 | 34709266 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DPH2 HSPG2 SHROOM3 PIEZO1 NOB1 ZBTB4 AHDC1 CIC BAP1 PRR12 KMT2D ZFP36L2 KCNH2 TMCC2 SCN8A TNFAIP3 AGRN IL4R CRAMP1 PRRC2B BAHCC1 | 8.21e-10 | 1105 | 129 | 21 | 35748872 |
| Pubmed | The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. | 4.99e-08 | 3 | 129 | 3 | 26551667 | |
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 36563677 | ||
| Pubmed | TET2 SHROOM3 UBAP2 PITRM1 PIEZO1 NACA HEPH BAP1 UNK CARNS1 CRAMP1 MGRN1 | 7.08e-07 | 529 | 129 | 12 | 14621295 | |
| Pubmed | 7.67e-07 | 268 | 129 | 9 | 33640491 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | AHCTF1 TNRC6B AHDC1 CIC RBM20 PRR12 KMT2D TLE3 GLUD1 PRORP PRRC2B | 1.18e-06 | 457 | 129 | 11 | 32344865 |
| Pubmed | Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice. | 1.73e-06 | 7 | 129 | 3 | 11802174 | |
| Pubmed | The Piezo channel is a mechano-sensitive complex component in the mammalian inner ear hair cell. | 2.75e-06 | 8 | 129 | 3 | 38228630 | |
| Pubmed | Dietary excess regulates absorption and surface of gut epithelium through intestinal PPARα. | 2.75e-06 | 8 | 129 | 3 | 34857752 | |
| Pubmed | ERCC6 PSD TTC28 VPS4A AHCTF1 TNRC6B CHD3 RFC4 PLEKHN1 ZNF469 SLC25A12 ZBTB10 CSMD1 PRRC2B VCP BAHCC1 | 4.05e-06 | 1116 | 129 | 16 | 31753913 | |
| Pubmed | TET2 HSPG2 UBAP2 PITRM1 NACA TNRC6B CHD3 CIC RBM20 BAP1 PRR12 KMT2D TLE3 GLUD1 ZSCAN18 ZBTB10 UNK PRRC2B | 5.84e-06 | 1429 | 129 | 18 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 6.94e-06 | 351 | 129 | 9 | 38297188 | |
| Pubmed | A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling. | 8.05e-06 | 11 | 129 | 3 | 29887373 | |
| Pubmed | 1.07e-05 | 12 | 129 | 3 | 16750824 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.18e-05 | 135 | 129 | 6 | 28675934 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 34173171 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 28621566 | ||
| Pubmed | Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma. | 1.37e-05 | 2 | 129 | 2 | 25506919 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 17428789 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 32078638 | ||
| Pubmed | [Feeling the pressure? Identification of two proteins activated by mechanical forces]. | 1.37e-05 | 2 | 129 | 2 | 21299953 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 23595828 | ||
| Pubmed | Identification of pauses during formation of HIV-1 virus like particles. | 1.37e-05 | 2 | 129 | 2 | 24268138 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 10393249 | ||
| Pubmed | Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development. | 1.37e-05 | 2 | 129 | 2 | 38395992 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 33703976 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 37820892 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21621574 | ||
| Pubmed | Mechanisms of mechanotransduction and physiological roles of PIEZO channels. | 1.37e-05 | 2 | 129 | 2 | 39251883 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 28911206 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 37975162 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22875990 | ||
| Pubmed | Influenza virus budding does not require a functional AAA+ ATPase, VPS4. | 1.37e-05 | 2 | 129 | 2 | 20621136 | |
| Pubmed | Transduction of Repetitive Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels. | 1.37e-05 | 2 | 129 | 2 | 28636944 | |
| Pubmed | Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. | 1.37e-05 | 2 | 129 | 2 | 15578726 | |
| Pubmed | Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes. | 1.37e-05 | 2 | 129 | 2 | 15044002 | |
| Pubmed | Induction of excitatory and inhibitory presynaptic differentiation by GluD1. | 1.37e-05 | 2 | 129 | 2 | 22138648 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 34220417 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 25037583 | ||
| Pubmed | Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues. | 1.37e-05 | 2 | 129 | 2 | 26241911 | |
| Pubmed | Comparative sequence and expression analyses of four mammalian VPS4 genes. | 1.37e-05 | 2 | 129 | 2 | 12594041 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21446915 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 16103356 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 9211789 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 38060673 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 24593767 | ||
| Pubmed | The role of PIEZO ion channels in the musculoskeletal system. | 1.37e-05 | 2 | 129 | 2 | 36717101 | |
| Pubmed | Potentiation of neuronal activity by tonic GluD1 current in brain slices. | 1.37e-05 | 2 | 129 | 2 | 37154294 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22924626 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 11563910 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 11032875 | ||
| Pubmed | A Plug-and-Latch Mechanism for Gating the Mechanosensitive Piezo Channel. | 1.37e-05 | 2 | 129 | 2 | 32142647 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 11787818 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 34464353 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 29943084 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 31898404 | ||
| Pubmed | Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux. | 1.37e-05 | 2 | 129 | 2 | 15378063 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 27422263 | ||
| Pubmed | Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer. | 1.37e-05 | 2 | 129 | 2 | 31930723 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15750346 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 1711373 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19278657 | ||
| Pubmed | Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate. | 1.37e-05 | 2 | 129 | 2 | 20529287 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 25124006 | ||
| Pubmed | Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase. | 1.37e-05 | 2 | 129 | 2 | 23673664 | |
| Pubmed | Lack of evidence for direct ligand-gated ion channel activity of GluD receptors. | 1.37e-05 | 2 | 129 | 2 | 39052831 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 24442550 | ||
| Pubmed | The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity. | 1.37e-05 | 2 | 129 | 2 | 27137930 | |
| Pubmed | GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution. | 1.37e-05 | 2 | 129 | 2 | 26440896 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 12742085 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 30324494 | ||
| Pubmed | Analysis of individual HIV-1 budding event using fast AFM reveals a multiplexed role for VPS4. | 1.37e-05 | 2 | 129 | 2 | 36042696 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 18688271 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 33326793 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22658952 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21056836 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 30745454 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 25695618 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 38124277 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19015267 | ||
| Pubmed | Astrocytes in the optic nerve head express putative mechanosensitive channels. | 1.37e-05 | 2 | 129 | 2 | 26236150 | |
| Pubmed | Touch, Tension, and Transduction - The Function and Regulation of Piezo Ion Channels. | 1.37e-05 | 2 | 129 | 2 | 27743844 | |
| Pubmed | Axonal and Glial PIEZO1 and PIEZO2 Immunoreactivity in Human Clitoral Krause's Corpuscles. | 1.37e-05 | 2 | 129 | 2 | 38928429 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 30628892 | ||
| Pubmed | Piezo1 ion channel pore properties are dictated by C-terminal region. | 1.37e-05 | 2 | 129 | 2 | 26008989 | |
| Pubmed | Human GLUD1 and GLUD2 glutamate dehydrogenase localize to mitochondria and endoplasmic reticulum. | 1.37e-05 | 2 | 129 | 2 | 19448744 | |
| Pubmed | Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. | 1.37e-05 | 2 | 129 | 2 | 20813920 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 31300459 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 11950837 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 31311407 | ||
| Pubmed | Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. | 1.39e-05 | 13 | 129 | 3 | 19373254 | |
| Pubmed | 1.39e-05 | 13 | 129 | 3 | 12682087 | ||
| Pubmed | 1.50e-05 | 83 | 129 | 5 | 28794006 | ||
| Pubmed | 2.21e-05 | 225 | 129 | 7 | 12168954 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | UBAP2 TTC28 MARK3 VPS4A VPS4B RFC4 BAP1 USP5 TNFAIP3 ALDH9A1 USP15 RPL3L PRRC2B VCP | 2.32e-05 | 1005 | 129 | 14 | 19615732 |
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 2.69e-05 | 16 | 129 | 3 | 17948866 | |
| Pubmed | 3.26e-05 | 17 | 129 | 3 | 20622874 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | CUX2 NKX6-2 AHCTF1 ZBTB4 CIC KMT2D FOXL2 SOX21 ZFP36L2 DLX4 GRHL3 ONECUT3 CRAMP1 | 3.49e-05 | 908 | 129 | 13 | 19274049 |
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 21238931 | ||
| Interaction | SOX7 interactions | 9.05e-07 | 82 | 128 | 7 | int:SOX7 | |
| Interaction | SP7 interactions | TET2 PITRM1 CHD3 CIC RBM20 PRR12 KMT2D TLE3 GLUD1 DLX4 PRRC2B | 3.91e-06 | 304 | 128 | 11 | int:SP7 |
| Interaction | KLF5 interactions | 4.37e-06 | 195 | 128 | 9 | int:KLF5 | |
| Interaction | GCM1 interactions | 4.63e-06 | 68 | 128 | 6 | int:GCM1 | |
| Interaction | TLE3 interactions | TET2 ZBTB4 AHDC1 CIC RBM20 BAP1 PRR12 KMT2D CAPN7 TLE3 ZSCAN18 VCP | 5.08e-06 | 376 | 128 | 12 | int:TLE3 |
| Interaction | TBR1 interactions | 7.81e-06 | 113 | 128 | 7 | int:TBR1 | |
| Interaction | TOP3B interactions | DPH2 HSPG2 SHROOM3 UBAP2 PIEZO1 NOB1 ZBTB4 TNRC6B AHDC1 CIC BAP1 PRR12 KMT2D ZFP36L2 KCNH2 TMCC2 SCN8A UNK TNFAIP3 AGRN IL4R CRAMP1 PRRC2B BAHCC1 | 1.61e-05 | 1470 | 128 | 24 | int:TOP3B |
| Interaction | CAPRIN1 interactions | UBAP2 MARK3 TNRC6B CHD3 RFC4 BAP1 ZFP36L2 GLUD1 ZBTB10 UNK PRRC2B VCP | 3.10e-05 | 451 | 128 | 12 | int:CAPRIN1 |
| Interaction | TTR interactions | 4.27e-05 | 100 | 128 | 6 | int:TTR | |
| Interaction | CSTF1 interactions | 5.32e-05 | 104 | 128 | 6 | int:CSTF1 | |
| Interaction | PAX8 interactions | 7.66e-05 | 111 | 128 | 6 | int:PAX8 | |
| Interaction | KDM1A interactions | TET2 TTC28 VPS4B TNRC6B CHD3 CIC RBM20 SFMBT2 PALB2 BAP1 PRR12 KMT2D SLC4A1AP TLE3 ZBTB10 UNK USP15 | 9.65e-05 | 941 | 128 | 17 | int:KDM1A |
| GeneFamily | AAA ATPases | 4.36e-06 | 53 | 83 | 5 | 413 | |
| GeneFamily | AAA ATPases|ESCRT-IV | 6.23e-05 | 3 | 83 | 2 | 1120 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 4.31e-04 | 7 | 83 | 2 | 570 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.04e-04 | 34 | 83 | 3 | 487 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 7.34e-04 | 9 | 83 | 2 | 527 | |
| GeneFamily | C2 domain containing|Calpains | 2.10e-03 | 15 | 83 | 2 | 975 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.71e-03 | 17 | 83 | 2 | 1197 | |
| Coexpression | GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN | 2.08e-06 | 170 | 129 | 8 | M9445 | |
| Coexpression | DASU_IL6_SIGNALING_SCAR_UP | 1.59e-05 | 31 | 129 | 4 | M292 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-08 | 175 | 129 | 8 | c3d3f11602379aaba65842a98835299e54fccd84 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-08 | 184 | 129 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-08 | 184 | 129 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-08 | 184 | 129 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-07 | 197 | 129 | 8 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-07 | 160 | 129 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-07 | 160 | 129 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-06 | 183 | 129 | 7 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | COVID-19_Severe-Neu_1|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 1.83e-06 | 198 | 129 | 7 | bbe639ea5a636c985e509fb0a133ae3b60afac5a | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-06 | 199 | 129 | 7 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | COVID-19_Severe-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 1.89e-06 | 199 | 129 | 7 | e4d8bf016fd95a440e30014a75587e097e90cfad | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-BMP_responsible_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-06 | 200 | 129 | 7 | 26251ed8c7fa7e87973d6f59bd398c88ad025395 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Glia_progenitor_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-06 | 200 | 129 | 7 | 4b937b1d0179d1d0e51931f35720e205d460a07e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.24e-06 | 151 | 129 | 6 | 2dc132895609e4efe17954e31f53d9c1ccf256ef | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 5.24e-06 | 151 | 129 | 6 | 5906562efd36fbcb91f96e0a0d3a8fe999ba1e79 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.24e-06 | 151 | 129 | 6 | 22afd8201eff8471da3456be065f2790de5e4bfe | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.30e-06 | 160 | 129 | 6 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_HSPB3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 170 | 129 | 6 | 985c6c9e3c593ed0628a481f06c2c91b2ab5d746 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 170 | 129 | 6 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 170 | 129 | 6 | 513d9036aa41d4d902da8baa66a66206abb6f3b0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-05 | 174 | 129 | 6 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.57e-05 | 183 | 129 | 6 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 183 | 129 | 6 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 183 | 129 | 6 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.72e-05 | 186 | 129 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.12e-05 | 193 | 129 | 6 | 7839040e703877ef321494ad8926a8604729ceda | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.12e-05 | 193 | 129 | 6 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.18e-05 | 194 | 129 | 6 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.24e-05 | 195 | 129 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.24e-05 | 195 | 129 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 2.24e-05 | 195 | 129 | 6 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-05 | 196 | 129 | 6 | f811958823380069077754283e36106d80147494 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-05 | 197 | 129 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-05 | 197 | 129 | 6 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-05 | 197 | 129 | 6 | 4d3670456655248250d156f92de01df4aa481733 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.38e-05 | 197 | 129 | 6 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Myeloid-Microglia|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.44e-05 | 198 | 129 | 6 | 901cd39cb84f1907f2f5d27221979c854bd3b40e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Myeloid|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.44e-05 | 198 | 129 | 6 | cc292aa8518d5ef8940e2327f2f07d584a996d90 | |
| ToppCell | Transverse-B_cell-B_cell_IgG_Plasma|Transverse / Region, Cell class and subclass | 2.44e-05 | 198 | 129 | 6 | a4ece1fe3d15acfde0e6ff14cddb3a3d16f61ce0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-05 | 198 | 129 | 6 | 0d9d401190792fd61434f1b82548253187d805f0 | |
| ToppCell | Transverse-(2)_B_cell-(21)_B_cell_IgG_Plasma|Transverse / shred on region, Cell_type, and subtype | 2.44e-05 | 198 | 129 | 6 | d6052b5a44246798e90f4779cd940ffac7539fcd | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.51e-05 | 199 | 129 | 6 | d3f36ede2fade550ec8f21a0448e71e1ff579ee2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.51e-05 | 199 | 129 | 6 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-05 | 199 | 129 | 6 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-FILIP1L|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.59e-05 | 200 | 129 | 6 | f6af5ef02625aaae21e885e1ebd195e34731e53a | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-FILIP1L-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.59e-05 | 200 | 129 | 6 | 53f61e28c3ad6399f63c54e06120ecb5ebbf90d9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.59e-05 | 200 | 129 | 6 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-FILIP1L--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.59e-05 | 200 | 129 | 6 | c1f243ae929f7791e040437470033abf749b44cc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.59e-05 | 200 | 129 | 6 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.59e-05 | 200 | 129 | 6 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.59e-05 | 200 | 129 | 6 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | PBMC-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 8.10e-05 | 152 | 129 | 5 | 1a3f8ed476aa9a39742b4684be2c704669e4a3d0 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 8.35e-05 | 153 | 129 | 5 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.15e-05 | 156 | 129 | 5 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 159 | 129 | 5 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.00e-04 | 159 | 129 | 5 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 159 | 129 | 5 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 162 | 129 | 5 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 162 | 129 | 5 | f945688815229c8386cbcbf46deee7df316fa8d3 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 1.12e-04 | 163 | 129 | 5 | 7d7f18e5c99be125e95bc180823430291b770d05 | |
| ToppCell | Adult-Immune-B_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.12e-04 | 163 | 129 | 5 | 4f5821299b265663c7d0352b28285f56e1988841 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 164 | 129 | 5 | 939d4e3911fce185b986639c815de0a0389f6cfd | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.16e-04 | 164 | 129 | 5 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 164 | 129 | 5 | 3281f2452cc6b11f3e030a3942002b9457dde6fe | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 164 | 129 | 5 | d6806deabf5f5c355934387be2baae125ac33fb8 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.19e-04 | 165 | 129 | 5 | b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-9|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.23e-04 | 166 | 129 | 5 | 68e6fc7c0040bbe48a93f96ecf28afffdc626845 | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.23e-04 | 166 | 129 | 5 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | droplet-Liver-LIVER|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 167 | 129 | 5 | 90125bfdc34b0f9a471cefe6e8a637d5e5e00790 | |
| ToppCell | droplet-Liver-LIVER-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 167 | 129 | 5 | 4bbc59cc50a68b957125fb11a3b308fe1d542ce9 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 167 | 129 | 5 | a038c522e4783cb62802f613d00bd5f3e3797199 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-04 | 167 | 129 | 5 | cb650f74306fa0d9f4bf49890b73065d193b94dc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 168 | 129 | 5 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 1.30e-04 | 168 | 129 | 5 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 168 | 129 | 5 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 169 | 129 | 5 | 44d201361eb497222a4972a0e10bac1e05dcfd0a | |
| ToppCell | -SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.37e-04 | 170 | 129 | 5 | 601630644f09133ee4c5e64499460b55cf3e80a0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-04 | 170 | 129 | 5 | 3174ea9cf93892a8b41de10fd4ff6f06bb41502d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 171 | 129 | 5 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 171 | 129 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.41e-04 | 171 | 129 | 5 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 172 | 129 | 5 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 172 | 129 | 5 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 172 | 129 | 5 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.49e-04 | 173 | 129 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-04 | 173 | 129 | 5 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-04 | 173 | 129 | 5 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.53e-04 | 174 | 129 | 5 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 174 | 129 | 5 | dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89 | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.57e-04 | 175 | 129 | 5 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.57e-04 | 175 | 129 | 5 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.57e-04 | 175 | 129 | 5 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-04 | 175 | 129 | 5 | ba1befc4e5f0167452f9ceace39377d16136dfa9 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 175 | 129 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.57e-04 | 175 | 129 | 5 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 176 | 129 | 5 | 6b4afd2c9268172063fe5832896bea15e862579e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 176 | 129 | 5 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 176 | 129 | 5 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class | 1.65e-04 | 177 | 129 | 5 | 34e9455790bae905dd91923792f4109d18b7686e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-04 | 177 | 129 | 5 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 9.24e-07 | 185 | 126 | 9 | 5585_DN | |
| Drug | valproate | SHROOM3 CUX2 SFMBT2 RYR3 FGL2 SLC6A11 CSF2RB KCNH2 GLUD1 GLUD2 UGT2B4 | 9.09e-06 | 381 | 126 | 11 | CID000003121 |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.06e-05 | 189 | 126 | 8 | 5578_DN | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 126 | 8 | 4805_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 126 | 8 | 2848_UP | |
| Drug | ADP-ribosylcysteine | 2.64e-05 | 11 | 126 | 3 | CID003035804 | |
| Drug | phenyltriethoxysilane | 3.04e-05 | 2 | 126 | 2 | CID000013075 | |
| Drug | G-3SH | 3.04e-05 | 2 | 126 | 2 | CID000174237 | |
| Drug | iodoacetyldiethylstilbestrol | 3.04e-05 | 2 | 126 | 2 | CID006455327 | |
| Drug | methylmercuric bromide | 3.04e-05 | 2 | 126 | 2 | CID000068175 | |
| Drug | 5-methylisophthalate | 3.04e-05 | 2 | 126 | 2 | CID000068137 | |
| Drug | x 1 s | 3.04e-05 | 2 | 126 | 2 | CID000409694 | |
| Disease | atrial fibrillation | 4.63e-06 | 371 | 126 | 10 | EFO_0000275 | |
| Disease | Lymphoma, Follicular, Grade 2 | 3.33e-05 | 15 | 126 | 3 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 3.33e-05 | 15 | 126 | 3 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 3.33e-05 | 15 | 126 | 3 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 3.33e-05 | 15 | 126 | 3 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 3.33e-05 | 15 | 126 | 3 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 3.33e-05 | 15 | 126 | 3 | C0079758 | |
| Disease | Pulmonary alveolar proteinosis, congenital | 5.41e-05 | 3 | 126 | 2 | C2931035 | |
| Disease | fascioliasis (biomarker_via_orthology) | 5.41e-05 | 3 | 126 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | Lymphoma, Follicular | 8.22e-05 | 20 | 126 | 3 | C0024301 | |
| Disease | Sezary Syndrome | 2.06e-04 | 27 | 126 | 3 | C0036920 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 2.68e-04 | 6 | 126 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | QRS duration | 3.03e-04 | 298 | 126 | 7 | EFO_0005055 | |
| Disease | ascending aortic diameter | 3.45e-04 | 140 | 126 | 5 | EFO_0021787 | |
| Disease | vanillylmandelate (VMA) measurement | 3.75e-04 | 7 | 126 | 2 | EFO_0800119 | |
| Disease | hematocrit | COL4A3 SHROOM3 UBAP2 PITRM1 PIEZO1 TNRC6B CHD3 CR1 PRR12 PRDM8 ZBTB10 BAHCC1 MGRN1 | 3.98e-04 | 1011 | 126 | 13 | EFO_0004348 |
| Disease | diverticular disease | 5.44e-04 | 236 | 126 | 6 | EFO_0009959 | |
| Disease | Paroxysmal atrial fibrillation | 5.66e-04 | 156 | 126 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 5.66e-04 | 156 | 126 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 5.66e-04 | 156 | 126 | 5 | C2585653 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 6.10e-04 | 90 | 126 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | Atrial Fibrillation | 6.34e-04 | 160 | 126 | 5 | C0004238 | |
| Disease | gamma-glutamylisoleucine measurement | 6.39e-04 | 9 | 126 | 2 | EFO_0021139 | |
| Disease | albuminuria | 7.18e-04 | 94 | 126 | 4 | EFO_0004285 | |
| Disease | Leukemia, Myelocytic, Acute | 9.01e-04 | 173 | 126 | 5 | C0023467 | |
| Disease | Microphthalmos | 9.70e-04 | 11 | 126 | 2 | C0026010 | |
| Disease | alcohol and nicotine codependence | 1.37e-03 | 13 | 126 | 2 | EFO_0004776 | |
| Disease | gamma-glutamylleucine measurement | 1.37e-03 | 13 | 126 | 2 | EFO_0021140 | |
| Disease | Connective Tissue Diseases | 1.37e-03 | 13 | 126 | 2 | C0009782 | |
| Disease | corpus callosum posterior volume measurement | 1.44e-03 | 52 | 126 | 3 | EFO_0010298 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 1.83e-03 | 15 | 126 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | glycerate measurement | 1.83e-03 | 15 | 126 | 2 | EFO_0021029 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.83e-03 | 15 | 126 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Spondyloepiphyseal Dysplasia | 2.09e-03 | 16 | 126 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 2.09e-03 | 16 | 126 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 2.09e-03 | 16 | 126 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 2.09e-03 | 16 | 126 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 2.09e-03 | 16 | 126 | 2 | C0025237 | |
| Disease | Malignant neoplasm of breast | COL11A1 ERCC6 LAMA2 RFC4 CIC PALB2 BAP1 KMT2D TLE3 C1QB SPOCD1 RAD54L | 2.21e-03 | 1074 | 126 | 12 | C0006142 |
| Disease | psoriasis vulgaris | 2.28e-03 | 61 | 126 | 3 | EFO_1001494 | |
| Disease | disease progression measurement | 2.28e-03 | 61 | 126 | 3 | EFO_0008336 | |
| Disease | Van Buchem disease | 2.36e-03 | 17 | 126 | 2 | C0432272 | |
| Disease | MHPG measurement, 5-HIAA measurement | 2.36e-03 | 17 | 126 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | bitter alcoholic beverage consumption measurement | 2.58e-03 | 133 | 126 | 4 | EFO_0010092 | |
| Disease | Global developmental delay | 2.58e-03 | 133 | 126 | 4 | C0557874 | |
| Disease | peritonsillar abscess | 2.65e-03 | 18 | 126 | 2 | EFO_0007429 | |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 2.95e-03 | 19 | 126 | 2 | EFO_0007709 | |
| Disease | Osteochondrodysplasias | 2.95e-03 | 19 | 126 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 2.95e-03 | 19 | 126 | 2 | C0013366 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 2.95e-03 | 19 | 126 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 2.95e-03 | 19 | 126 | 2 | C2936783 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.03e-03 | 139 | 126 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 3.11e-03 | 140 | 126 | 4 | C0005695 | |
| Disease | Intellectual Disability | 3.15e-03 | 447 | 126 | 7 | C3714756 | |
| Disease | Malignant neoplasm of urinary bladder | 3.19e-03 | 141 | 126 | 4 | C0005684 | |
| Disease | Multiple Epiphyseal Dysplasia | 3.27e-03 | 20 | 126 | 2 | C0026760 | |
| Disease | breast cancer, COVID-19 | 3.95e-03 | 22 | 126 | 2 | MONDO_0007254, MONDO_0100096 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | 3.95e-03 | 22 | 126 | 2 | EFO_0005199, EFO_0005208, EFO_0007892 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 3.95e-03 | 74 | 126 | 3 | DOID:3748 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNGSEPTGAYPIKGF | 191 | Q10588 | |
| PGLPKSGLDKSGYFE | 481 | Q9P281 | |
| SPVELPFGGYKKSGF | 451 | P49189 | |
| GKSGTVLSPGFPDFY | 936 | Q96PZ7 | |
| SGLPGESYGSEKGAP | 276 | Q01955 | |
| FSGKGDITKPGYDPC | 241 | Q5XX13 | |
| ARDGGFPPFSSYEKL | 2641 | Q6V0I7 | |
| PALPKAYGTGFVGCL | 2026 | O00468 | |
| SGAGPAGPYAKESGI | 286 | Q9BZP6 | |
| LDYEISFGGIPAPGK | 306 | Q9C0A0 | |
| FTYKPPGLLRGGDAS | 111 | A5YM72 | |
| AFYVGGSKASPDPDL | 216 | Q9BQC3 | |
| GFSPESKGYAIGNAP | 121 | Q92560 | |
| SALGYKDLGPGSPQT | 56 | A6NHC0 | |
| SPPYEGKVGTGLLAD | 1476 | Q5TGY3 | |
| AGGLLVFPPAFYGAK | 501 | O14529 | |
| DLPKAGTLPTSGYGN | 206 | Q92988 | |
| LAGPSPYLGRFKVGS | 381 | Q7L9B9 | |
| SGDGTDYELKPLPKG | 396 | Q03468 | |
| IGKTGPAPATAGFYE | 216 | Q5T481 | |
| YPDYGAIPKAGLSSG | 3801 | P98160 | |
| GALDLFPPGYSSKAL | 476 | Q92698 | |
| SGDGTDYELKPLPKG | 396 | P0DP91 | |
| ASKAGLPGFYDPCVG | 506 | Q9NVH1 | |
| TPLGNGDLALKFGYP | 26 | Q6ZST4 | |
| GDLALKFGYPTPHGG | 31 | Q6ZST4 | |
| GLRYSLPTPKGGKYA | 321 | Q9ULX3 | |
| YSGKRKGPDSLSDGP | 161 | Q9BYH8 | |
| PGLAEGRPSLYAGDK | 571 | Q9BXT6 | |
| GEKFDTPHPEGYLFG | 41 | O60291 | |
| PYNSSGLGGPSIKDK | 596 | Q12809 | |
| PFRYGGDGSKGPTIS | 496 | P12107 | |
| KFFYAGTPPAGLAAD | 36 | O94919 | |
| PDDLIKPGLFKGTYG | 296 | Q5XUX0 | |
| DRTKPFFSLGLGAPG | 101 | Q7Z5P9 | |
| GYPSEPLGGLEQKAA | 81 | A2RU67 | |
| KGLAGPAASYGPYTR | 246 | P58012 | |
| PPGAGKSTFIEYFGK | 151 | Q8IVH4 | |
| DKCLPGFYGEPTKGT | 786 | P24043 | |
| PAFDALGQLTGGYKP | 151 | P00973 | |
| DPGGSAFLKVDPAYL | 6 | Q9NQX0 | |
| LGTTPAFGPQGSYEK | 731 | Q86YC2 | |
| YPLRGSSIFGLAPGK | 386 | P10696 | |
| SVSFGLFYKPSPDAG | 271 | P32927 | |
| GPPGEAGYKAFSSLL | 596 | P24394 | |
| GQFYPVTLRTPAGGK | 256 | Q8TE85 | |
| DPGPHGFLRKSSGDY | 751 | Q9Y6W3 | |
| TGTPFGDIPYGKEIS | 1786 | P17927 | |
| ESPKLPSGAYEGGAL | 1041 | Q12873 | |
| GSILGFPKAKPYEGS | 356 | P00367 | |
| SDKLFPAYGFGAKLP | 346 | Q8IYJ1 | |
| YGEGVPLSPAKLNGS | 1111 | Q96RY5 | |
| APGPKGESGDYKATQ | 106 | P02746 | |
| GGKLDTFCGSPPYAA | 206 | P27448 | |
| PGVSEAHPGGYKSSF | 411 | Q14314 | |
| YFKGRGLDLGTFPNP | 66 | Q6UXQ4 | |
| KRDEGGTGKYPPASL | 741 | Q8WYP5 | |
| AKPPGAAEEASGKYG | 311 | A6NMB9 | |
| GGLGTTFKFLPASEP | 646 | Q9C0B2 | |
| GSILGFPKAKPYEGS | 356 | P49448 | |
| SPGSSGVPYANAKGI | 6 | A1KXE4 | |
| AAVPLLGGSKYGASP | 696 | O75473 | |
| AAYGPPGHLAGDKLL | 226 | O60422 | |
| KYSAAPDSGGAPGVS | 961 | Q10571 | |
| TGGLEGSHYLPPTKF | 421 | Q9Y4I5 | |
| FYGPPGTGKTSTILA | 76 | P35249 | |
| PLAGSYGAADSFPKD | 11 | Q9HB90 | |
| TLPGAGAGIKFYLYP | 266 | P31641 | |
| SSGPAGPYLLSKKGA | 511 | Q494U1 | |
| KFAFPVPYGLGGVAD | 91 | Q9Y651 | |
| EFFYGSLDPPSSGAK | 241 | A5PKW4 | |
| GPGGALGSPKSNALY | 496 | O75069 | |
| PKGLAGLGIPFLYGS | 116 | Q7Z3H4 | |
| PGGLKGSARFLSFGP | 26 | H3BV60 | |
| KTSLFPYALQGPAGF | 26 | Q9C056 | |
| AKSITPLGGFPHYGE | 311 | Q92901 | |
| QGSAPSPGKKLRGFY | 16 | P0DJD1 | |
| FDYITEKGPLGEGPS | 126 | Q9P1W9 | |
| FVGFSSKPSPIYGGL | 16 | P03923 | |
| GGGLPKQSPFLYATA | 566 | Q9NQV8 | |
| SEGSLYPDGSSGPLK | 136 | Q9BQS7 | |
| GPNSPFYKALIESGL | 356 | Q5JRX3 | |
| LGSPKPEDGEYKFGA | 761 | Q1XH10 | |
| FGLVKDPCYLAGPGS | 1261 | Q8TF72 | |
| YKGPGPGIKFSAEAL | 126 | P15907 | |
| KLALGSFFDDGPGIY | 341 | B3KU38 | |
| KGAFGPTPLYRAAFG | 221 | A8MXQ7 | |
| GSPGAPGKYLSSVLA | 581 | Q9ULL5 | |
| KSPYLGLGPGHSYVS | 16 | O15091 | |
| AGYPKPIFKGFGGLT | 1226 | Q92954 | |
| YIDFGGLKPAGSEPT | 606 | O75746 | |
| PVAFGKGYGSAPSSS | 521 | Q96RK0 | |
| LLFGPPGTGKSYLAK | 171 | O75351 | |
| PYPGDVTKFGRGDSA | 861 | Q5T6F2 | |
| PGKGPEFLFTLYSAG | 61 | A0A0B4J274 | |
| GSNFAPLKVGGIYLP | 221 | P21580 | |
| FYGPPGCGKTLLAKA | 516 | P55072 | |
| KGRPGFYFGELPLSL | 241 | Q8NER1 | |
| PGYAIEKHSGGLLFP | 176 | P06133 | |
| GDGGLYSSLPPAKRE | 331 | P08138 | |
| ESKGGGSHPLLVPYD | 2756 | Q15413 | |
| GTEKFGYLPATGDGP | 281 | Q6ZMY3 | |
| GVSLTPPKGYSGQDF | 366 | Q5VUG0 | |
| KVSPPSLGFLAGYGI | 2656 | Q9H5I5 | |
| YPGPIDNSGLLKDGD | 61 | Q9Y4E8 | |
| SPGLLASEKTPNGGY | 391 | Q9P1Z0 | |
| KGAGALPFLPGVFGY | 956 | Q9P1Z0 | |
| TKPLDYSGPGDSFDG | 121 | Q8TBZ2 | |
| ILSGGTALKPPYSAF | 2011 | Q5JSZ5 | |
| AESGPGLAFIAYPKA | 371 | P48066 | |
| AGKSLPFIYGDIPQG | 61 | Q9UQD0 | |
| TANKESGGGYEPPLT | 411 | Q9Y2I9 | |
| PSDFGGTLPKYDGKA | 286 | P12271 | |
| SSLASIPGGKPAYSF | 436 | Q04726 | |
| AKAFPFPADGLGAEG | 666 | Q96JG9 | |
| LPSGNGYKFLSPGRF | 2461 | Q96AY4 | |
| EKSYALGGARGPQPS | 466 | Q8TBC5 | |
| GPSNDFKYGLIPGTS | 666 | Q96DT7 | |
| IPGTSNDFKYGLIPG | 676 | Q96DT7 | |
| KVSPPSLGFLAGYGI | 2426 | Q92508 | |
| APILEKPKGSSGGYG | 61 | Q8TF74 | |
| FPGESGLAPGSYKKA | 401 | Q9C0B0 | |
| GLAPGSYKKAPGFER | 406 | Q9C0B0 | |
| EKDEGPFYTHLGAGP | 1141 | Q6N021 | |
| AAGGPTSYGTLKEPS | 91 | P47974 | |
| PVLGAGSLNKDPSYS | 21 | Q96RL6 | |
| LVTPDEPKGSLGFYG | 621 | P45974 | |
| DLQTKGPIPGYGSGF | 1361 | Q9UPQ9 | |
| RGISSGYPFLKPAGI | 46 | Q6ZS27 | |
| FGPPGTGKSYLAKAV | 166 | Q9UN37 | |
| LSPLGELEYPFGAKG | 951 | O14686 | |
| ATLGFLFPSGPGSLK | 326 | Q96S06 | |
| YAGPDSAGPLLKSSL | 626 | E9PAV3 | |
| GPATAPYSLETLKGG | 161 | Q9BWU0 | |
| KQPAVDGGSPILGYF | 531 | P52179 |